Article
Identification of TRIM56 as a Potential Biomarker for Lung Adenocarcinoma
1 Mar 2021
Abstract excerpt
BACKGROUND: Lung adenocarcinoma (LUAD) is the primary subtype of human lung cancer. The effectiveness of treatment and long-term survival of patients with LUAD are current suboptimal. Tripartite motif containing 56 (TRIM56) is a member of the TRIM protein family that have functions predominantly in immunity and cancer. PURPOSE: To investigate the expression of TRIM56 in LUAD, and explore the potential regulatory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
